2024-09-18
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
after chutian technology (300358) senior executive lei yu was criminally detained, he resigned on september 17 for personal reasons.
on the evening of september 17, chutian technology announced that recently, the company received a notice from senior manager lei yu that the public security organ issued a "notice of execution of bail pending trial" and decided to release him on bail pending trial, with the period starting from september 14.
chutian technology also said,on september 17, the company received a written resignation report from senior executive lei yu, who resigned from the company's senior executive position for personal reasons and will continue to hold other positions in the company after leaving.his original term of office as a senior executive was until may 13, 2025. this matter will not affect the normal operation of the company's business. according to relevant regulations, his resignation report will take effect from the date of delivery to the company's board of directors.
chutian technology said that as of the announcement date, lei yu directly held 8,100 shares of the company.
on september 6, chutian technology disclosed the "announcement on major events".lei yu, a senior executive of the company, was detained by the public security authorities on suspicion of occupational embezzlement.
regarding the criminal detention of senior executive lei yu for suspected occupational embezzlement, a staff member of chutian technology's securities department responded to china news service on the 9th, saying:lei yu was not detained because of a report by the company, nor was the company involved, "he was brought out by other people."
according to chutian technology's 2024 semi-annual report, lei yu is the domestic sales president. it is worth noting that lei yu has been hired as a senior manager for less than 3 months.
on june 25, chutian technology announced that it had appointed lei yu as a senior executive in charge of domestic sales, with a term of office until the expiration of the fifth board of directors.lei yu has been working at chutian technology for 12 years.the resume disclosed by chutian technology at that time showed that lei yu, male, was born in january 1991, of chinese nationality, without permanent residency abroad, and had a bachelor's degree.he joined the company in february 2012 and is responsible for domestic sales.
an article published on the official wechat account of chutian technology on september 6 mentioned: on august 30, the 2024 biomedicine advanced technology seminar co-organized by chutian technology and suzhou biomedicine industry alliance was held in suzhou.lei yu, president of domestic sales of chutian technologydelivered a speech on behalf of chutian technology at the event.
lei yu said at the seminar that china's current biopharmaceutical industry is facing both challenges and opportunities. in july this year, the state council reviewed and approved the "implementation plan for full-chain support for innovative drug development", which means that from review and approval, access, use to capital support, especially innovative drugs referencing international pricing, basic medical insurance non-expenditure and other full-chain support for innovative drugs will soon become a reality, and china's biopharmaceutical industry will embark on a new path of innovation.
chutian technology was founded in 2000. it is a domestic pharmaceutical equipment provider and one of the top 100 pharmaceutical companies in china. its main products span the entire field of biological drugs, raw materials, traditional chinese medicines, chemical drugs, etc. its main businesses cover pharmaceutical water, bioengineering, sterile preparations, solid preparations, post-testing packaging and other sectors.
in terms of performance, chutian technology achieved revenue of 2.829 billion yuan in the first half of the year, a year-on-year decrease of 15.71%; the net profit attributable to shareholders of the listed company was -82.636 million yuan, a year-on-year decrease of 130.94%.
in the semi-annual report, chutian technology stated that the company faces the risk that its performance in 2024 may not meet expectations and the goals set at the beginning of the year may not be achieved. due to fierce competition in the industry, the company's gross profit margin has continued to decline, and the company's operating income and net profit attributable to shareholders have both declined year-on-year. if the company still cannot reverse this in the second half of this year, it may lead to a year-on-year decline in annual operating income and net profit, and the goals set at the beginning of the year cannot be achieved.
regarding the development in the second half of the year, chutian technology said that it will strengthen the development of international markets while strengthening the maintenance of the domestic market base. on the basis of maintaining the order volume and order gross profit margin, the company will maintain its important position in the domestic market and increase the industry concentration in the domestic market. at the same time, it will strengthen the sales of accessories and services, achieve product differentiation competition, and increase the domestic comprehensive gross profit margin.
in the secondary market, as of the close of september 18, chutian technology's share price was 6.1 yuan per share, with a total market value of 3.6 billion yuan. since the beginning of 2024, chutian technology's share price has fallen by more than 42%.